Treatment
Share your love
Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGR
\n \n The Ophthalmic Devices Market is witnessing robust expansion driven by rising demand for advanced eye care solutions, growing prevalence of vision disorders, and a rapidly aging population. Technological advancements such as AI-driven diagnostics, minimally invasive surgical systems, and…
Outlook Therapeutics requests Type A meeting with FDA following second CRL for ONS-5010
(Image Credit: AdobeStock) Outlook Therapeutics has requested a Type A meeting with the US Food and Drug Administration following the agency issuing a complete response letter (CRL) to its biologics license application (BLA) resubmission for ONS-5010 (bevacizumab-vikg) for the treatment…
Treating ophthalmic artery stenosis in geographic atrophy with angioplasty
(Image credit: AdobeStock/Rina) A study that evaluated the safety and feasibility of treating ophthalmic artery stenoses with angioplasty in patients with late-stage age-related macular degeneration (AMD) with geographic atrophy (GA) showed reported observing efficacy and functional improvement in this patient…
The state of retina at ASRS 2025 with Charles C. Wykoff, MD, PhD, and Kevin Quinn
(Image credit: AdobeStock/vetrana) The annual scientific meeting of the American Society of Retina Specialists (ASRS) was held in Long Beach, California from July 30 through August 2, 2025. At this event, researchers and experts in the retina field shared data…
New World Medical launches non-valved glaucoma drainage device, Ahmed ClearPath ST
(Image Credit: AdobeStock) New World Medical has launched Ahmed ClearPath ST, a non-valved glaucoma drainage device. The company stated in a press release that the Ahmed ClearPathST builds on the success of the Ahmed ClearPath by introducing key differences designed to…
Neurotech Pharmaceuticals appoints Peter J. McDonnell, MD, to Board of Directors
Photo of Peter J. McDonnell, MD, provided by Neurotech and used with permission Neurotech Pharmaceuticals, Inc., has appointed had Peter J. McDonnell, MD, to the Board of Directors. McDonnell, along with being a long-time member of the Ophthalmology Times Editorial…
EMA grants Orphan designations to MCO-010, FDA grants RMAT in Stargardt disease
(Image credit: AdobeStock/Pete) The European Medicines Agency (EMA) granted Orphan designations to MCO-010 (sonpiretigene isteparvovec) across 5 categories of retinal dystrophies. The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD). The EMA…
New insights show “later is better” for some LHON interventions
(Image Credit: AdobeStock/Brian Jackson) Neuro-ophthalmologist Alfredo Sadun, MD, PhD, has helped uncover surprising results from gene therapy research for Leber hereditary optic neuropathy (LHON), revealing effects far beyond the initially treated eye. LHON is a rare genetic disorder that causes…
An Interactive Corneal Sensitivity Testing Workshop
Thanks for your interest in this podcast. Please read this important program information before listening. Episode Description In this podcast, experts John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA; and John Hovanesian, MD, FACS; discuss the importance of comprehensive…
A study of the progression of sensitivity loss in GA over time using inferred data
(Image Credit: AdobeStock) The recent OMEGA study1 found that “inferred sensitivity” mapping may be a potential functional surrogate end point for geographic atrophy (GA) based on its ability to predict retinal function with high spatial resolution and without extensive psychophysical…